These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 3943463)
21. Clinical experience with rate-controlled delivery of antihypertensive therapy by a transdermal system. Weber MA; Drayer JI Am Heart J; 1984 Jul; 108(1):231-6. PubMed ID: 6375331 [TBL] [Abstract][Full Text] [Related]
22. Old wine into new bottles. A critical evaluation of transdermal clonidine in the treatment of hypertension. Mathias CJ Clin Auton Res; 1993 Dec; 3(6):355. PubMed ID: 8193520 [No Abstract] [Full Text] [Related]
24. One year efficacy and tolerability of clonidine administered by the transdermal route in patients with mild to moderate essential hypertension--a multicentre open label study. The Antihypertensive Patch Italian Study (APIS) Investigators. Clin Auton Res; 1993 Dec; 3(6):379-83. PubMed ID: 8193525 [TBL] [Abstract][Full Text] [Related]
25. Transcription medication error with transdermal clonidine. Mallet L; Cooper JW South Med J; 1988 Dec; 81(12):1597-8. PubMed ID: 3201308 [No Abstract] [Full Text] [Related]
26. Clonidine through the skin in the treatment of essential hypertension: is it practical? Groth H; Vetter H; Knüsel J; Boerlin HJ; Walger P; Baumgart P; Wehling M; Siegenthaler W; Vetter W J Hypertens Suppl; 1983 Dec; 1(2):120-2. PubMed ID: 6599488 [TBL] [Abstract][Full Text] [Related]
27. Treatment of chronic hypertension with intravenous enalaprilat and transdermal clonidine. Zawaideh MA; Duncan B; Joseph MW; Dixit MP Pediatr Nephrol; 2001 Jan; 16(1):85-6. PubMed ID: 11198612 [TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics and pharmacodynamics of clonidine in varying states of renal function. Lowenthal DT; Affrime MB; Meyer A; Kim KE; Falkner B; Sharif K Chest; 1983 Feb; 83(2 Suppl):386-90. PubMed ID: 6822133 [TBL] [Abstract][Full Text] [Related]
29. Therapeutic adherence in the elderly: transdermal clonidine compared to oral verapamil for hypertension. Burris JF; Papademetriou V; Wallin JD; Cook ME; Weidler DJ Am J Med; 1991 Jul; 91(1A):22S-28S. PubMed ID: 1867225 [TBL] [Abstract][Full Text] [Related]
31. Transdermal clonidine as an adjunct to sustained-release diltiazem in the treatment of mild-to-moderate hypertension. Lueg MC; Herron J; Zellner S Clin Ther; 1991; 13(4):471-81. PubMed ID: 1933999 [TBL] [Abstract][Full Text] [Related]
32. Transdermal clonidine (Catapres-TTS) monotherapy in the management of mild hypertension in general practice. Lewis GR N Z Med J; 1987 Nov; 100(836):711-3. PubMed ID: 3330602 [TBL] [Abstract][Full Text] [Related]
33. Transdermal clonidine for the treatment of essential hypertension. McChesney JA; Ryan C; Shaw RE; Fishman-Rosen J; Murphy MC Compr Ther; 1987 Apr; 13(4):49-53. PubMed ID: 3568603 [No Abstract] [Full Text] [Related]
34. Rebound hypertension during initiation of transdermal clonidine. Stewart M; Burris JF Drug Intell Clin Pharm; 1988; 22(7-8):573-4. PubMed ID: 3416742 [TBL] [Abstract][Full Text] [Related]
35. Transdermal clonidine as an adjunct to nifedipine-GITS therapy in patients with mild-to-moderate hypertension. Houston MC; Hays L Am Heart J; 1993 Oct; 126(4):918-23. PubMed ID: 8213450 [TBL] [Abstract][Full Text] [Related]
36. Utility of a transdermal delivery system for antihypertensive therapy. Part 1. Sclar DA; Skaer TL; Chin A; Okamoto MP; Gill MA Am J Med; 1991 Jul; 91(1A):50S-56S. PubMed ID: 1907801 [TBL] [Abstract][Full Text] [Related]
37. Kinetics of transdermal clonidine. Lin SK; Ribeiro LG Arch Intern Med; 1987 Sep; 147(9):1681, 1683. PubMed ID: 3632176 [No Abstract] [Full Text] [Related]